Mersana Therapeutics, Inc. June 23, 2023 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of investors who purchased Mersana Therapeutics, Inc. (Nasdaq: MRSN) securities. … Read MoreJoin Investigation
SentinelOne, Inc. June 15, 2023 – Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of SentinelOne, Inc. (“SentinelOne” or the “Company”) securities (NYSE: S) between June 1, 2022 and June 1, 2023, inclusive (the “Class Period”)…. Read MoreJoin Investigation
Funko, Inc. June 15, 2023 – Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of Funko, Inc. (“Funko” or the “Company”) common stock (NASDAQ: FNKO) between May 6, 2022 and March 1, 2023, inclusive (the “Class Period”)…. Read MoreJoin Investigation
Canopy Growth Corporation May 31, 2023 – Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of Canopy Growth Corporation (“Canopy Growth” or the “Company”) securities (NASDAQ: CGC) between May 31, 2022 and May 10, 2023, inclusive (the “Class Period”)…. Read MoreJoin Investigation
The Walt Disney Company May 24, 2023 – Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of The Walt Disney Company (“Disney” or the “Company”) common stock (NYSE: DIS) between December 10, 2020 and November 8, 2022, inclusive (the “Class Period”). … Read MoreJoin Investigation
Integra LifeSciences Holdings Corporation May 23, 2023 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of investors who purchased Integra LifeSciences Holdings Corporation (Nasdaq: IART) securities…. Read MoreJoin Investigation
Intercept Pharmaceuticals, Inc. May 22, 2023 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of investors who purchased Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) securities. … Read MoreJoin Investigation
Beyond Meat, Inc. May 17, 2023 – Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of Beyond Meat, Inc. (“Beyond Meat” or the “Company”) common stock (NASDAQ: BYND) between May 5, 2020 and October 13, 2022, inclusive (the “Class Period”). … Read MoreJoin Investigation
